SynthesisFrontiers in artificial intelligence2025
A systematic review of the hybrid machine learning models for brain tumour segmentation and detection in medical images.
Synthesis in Frontiers in artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early and accurate detection of brain tumours using Magnetic Resonance Imaging (MRI) is critical for effective treatment and improved patient outcomes. This systematic review investigates the application of hybrid machine learning (ML) and deep learning (DL) models in enhancing the computational efficiency and diagnostic accuracy of brain tumour analysis from MRI images. The study synthesizes recent advances in combining traditional ML models such as Support Vector Machines (SVM) with deep neural networks like VGG-19 and YOLOv10n. A PRISMA-based literature search strategy was employed across major databases, including PubMed, Scopus, and IEEE Xplore, selecting 25 relevant studies published between 2019 and 2024. The review evaluates the performance of standalone and hybrid models using metrics such as Dice Similarity Coefficient (DSC), Intersection over Union (IoU), accuracy, precision, recall, and F1-score. Findings indicate that hybrid models, particularly those combining SVM with CNN-based architectures like VGG-19, demonstrate improved classification accuracy and reduced false positives, outperforming single-model approaches. Lightweight versions such as YOLOv10n offer faster inference times suitable for real-time applications while maintaining competitive accuracy. Despite these advances, challenges remain in model generalizability, lack of large, annotated datasets, and limited adoption of Explainable AI (XAI) for interpretability. This review highlights the potential of hybrid models for brain tumour detection and offers recommendations for future research to focus on scalable, interpretable, and clinically deployable solutions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.